Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 210, Issue 3, Pages 456-466
Publisher
Oxford University Press (OUP)
Online
2014-02-15
DOI
10.1093/infdis/jiu095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
- (2013) Shashank Gupta et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
- (2013) Shashank Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
- (2012) Diana Machado et al. PLoS One
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery
- (2010) M. Balganesh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!
- (2010) Leonard Amaral et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis
- (2010) S. Sharma et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Mycobacterium tuberculosis Sigma Factor Network Responds to Cell-Envelope Damage by the Promising Anti-Mycobacterial Thioridazine
- (2010) Noton K. Dutta et al. PLoS One
- Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells
- (2010) Jasvir Dhillon et al. TUBERCULOSIS
- Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
- (2009) Susan E. Dorman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Shortening Treatment in Adults with Noncavitary Tuberculosis and 2-Month Culture Conversion
- (2009) John L. Johnson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
- (2009) G. E. Louw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Drug Resistance in Bacteria
- (2009) Xian-Zhi Li et al. DRUGS
- Verapamil for Cluster Headache. Clinical Pharmacology and Possible Mode of Action
- (2009) Peer Tfelt-Hansen et al. HEADACHE
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
- (2009) Clifton E. Barry et al. NATURE REVIEWS MICROBIOLOGY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux Mechanism
- (2008) F. S. Spies et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
- (2008) Anil Koul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now